Upgraded Q -> 2 from #26 [1693915911684] #45
Labels
2 (Med Risk)
Assets not at direct risk, but function/availability of the protocol could be impacted or leak value
M-01
primary issue
Highest quality submission among a set of duplicates
satisfactory
satisfies C4 submission criteria; eligible for awards
selected for report
This submission will be included/highlighted in the audit report
Judge has assessed an item in Issue #26 as 2 risk. The relevant finding follows:
Curve Read-only Reentrancy can increase the price of some CurveStableCollateral
The text was updated successfully, but these errors were encountered: